Linical Co (TSE:2183) Issuance of Debt: 円350 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2183 Linical Co Ltd TSE:2183
41 GF Score
Price 円213.00
GF Value 円330.24
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Linical Co Issuance of Debt?

Linical Co TSE:2183 +1.91% 41 Issuance of Debt is 円350 Mil as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 41/100 and a GF Value™ of 円330.24 (Possible Value Trap). The stock has 5 warning signs investors should review.

Linical Co's Issuance of Debt for the six months ended in Mar. 2026 was 円350 Mil.

Linical Co's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was 円350 Mil.

Linical Co Issuance of Debt Related Terms

Linical Co Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Linical Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Issuance of Debt Chart

Linical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 350.00

Linical Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 350.00
TSE:2183
41GF Score
Linical Co Ltd TSE:2183
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Linical Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円350 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of 円350 Mil mean?
Linical Co (TSE:2183) has a Issuance of Debt of 円350 Mil as of Mar. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Linical Co and its competitors.
Is Linical Co's Issuance of Debt too high?
Linical Co's current Issuance of Debt is 円350 Mil. Overall, Linical Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Issuance of Debt compare to VRTX and REGN?
Linical Co's Issuance of Debt of 円350 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Biotechnology company?
A good Issuance of Debt depends on the Biotechnology industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Linical Co and its competitors. Linical Co's current Issuance of Debt is 円350 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円330.24, compared to a current price of 円213.00 — trading 35.5% below its estimated fair value. The current Issuance of Debt is 円350 Mil. Linical Co's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Issuance of Debt is 円350 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円213.00 is trading 35.5% below its estimated GF Value™ of 円330.24. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

  • Issuance of Debt: 円350 Mil
  • GF Value™: 円330.24 vs. price of 円213.00 (35.5% below fair value)
  • GF Score™: 41/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Linical Co Business Description

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.
41GF Score

Get the complete analysis for TSE:2183

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円213.00
Price
円330.24
GF Value